TRAPPC9 and hyperprolactinemia: The SCH23390 and quinpirole treatment also effectively corrected the hyperinsulinemia and hyperprolactinemia in Trappc9-KO mice and resulted in corresponding changes in brain levels of cAMP (Supplemental Figure 3, B–D), indicating their actions in the brain.